Back to Financial results
ARVIND REMEDIES LTD
AUDITED FINANCIAL RESULTS
FOR THE YEAR ENDED MARCH 31, 2008
		(Rupees in Lakhs.)
Particulars	#######	3 months ended 31.03.2008	3 months ended 31.03.2007	Year ended 31.3.2008	Year ended 31.3.2007
		Unaudited	Unaudited	Unaudited	Audited
Gross Sales/Other Income	4595.8	5510.31	5066.66	20151.04	17972.93
Less:Exise Duty	-548.58	(703.68)	(702.31)	(2,583.89)	(2314.43)
NET SALES	4047.22	4,806.63	4364.35	17567.15	15658.50
Other Income	2.58	8.62	5.21	19.66	21.58
TOTL INCOME	4049.8	4815.25	4369.56	17586.81	15680.08
TOTAL EXPENDITURE
a) Increase/Decrease in stock	-255.62	(266.19)	(331.98)	(435.01)	(300.68)
b)  Consumption of Materials	3587.91	4372.7	4176.26	15283.14	13563.16
c)  Purchase of Traded Goods		-	-	30.69	84.47
d)  Staff Cost	92.52	154.63	90.45	441.04	340.42
e)  Other expenditure	130.54	147.52	153.03	649.87	618.13
Total (a) to (e)	3555.35	4,408.66	4087.76	15969.73	14305.50
Profit Before Int, Dep. and Tax	494.45	406.59	281.80	1617.08	1374.58
Interest	163.37	243.09	229.11	748.02	655.18
Depreciation	43.64	46.79	42.98	179.71	170.12
Profit before Tax	287.44	116.71	9.71	689.35	549.28
Provision for Taxation
Current   Tax Including FBT	26.73	67.23	19.73	147.23	85.86
Earlier Tax	0	-	(31.60)	-	(31.48)
Deferred Tax	-12.72	56.09	15.11	29.11	56.13
Wealth Tax	0	0.33	0.29	0.33	0.29
Profit after Tax	273.43	(6.94)	6.18	512.68	438.48
Paid-up Equity Share Capital	2600.5	2600.50	2600.50	2600.50	2600.50
Reserves excluding Revaluation Reserve				2033.98	1521.31
Basic and Diluted Earnings Per Share (Rs.)	0.11	-	0.01	0.20	0.17
(Not Annualised for the Quarter and Half Year)
Aggregate of Non-Promoter Shareholding
Number of shares	1.9E+08	194205340	194205340	194205340	194205340
Percentage of Shareholding	74.68%	74.68%	74.68%	74.68%	74.68%
Note :
1. The Company operates only in one business segment namely formulations.
2. Previous period figures have been regrouped / rearranged wherever necessary to confirm to the
current periods classification.
3. The Board of Directors have recommended a dividend of 5% subject to approval of the members.
4. The above results were reviewed by the audit committee and taken on record at the meeting of the
Board of Directors held on June 30, 2008.
5. During the  quarter 3  investor compliants were received and disposed off.  There were no
investor  compliants pending for the redressal as at the commencement and end of the quarter.
				For  ARVIND REMEDIES LTD
PLACE:CHENNAI 600 084				DR.B.Arvind Shah
DATE  : June 30, 2008				Managing Director
				Back to Financial results